Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.
about
Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISAHerpes simplex virus type 2 and HIV disease progression: a systematic review of observational studiesCharacteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.Performance of HSV-2 type specific serological tests in men in Kenya.Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.Herpes simplex virus infections among rural residents in eastern China.Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya.Herpes simplex virus type-2 seropositivity among ever married women in South and north Vietnam: a population-based study.Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban UgandansMature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countriesGlobal estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.Performance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.Herpes simplex virus type 2 serostatus is not associated with inflammatory or metabolic markers in antiretroviral therapy-treated HIVPrevalence and incidence estimation of HSV-2 by two IgG ELISA methods among South African women at high risk of HIV.The Epidemiology of Herpes Simplex Virus Type-2 Infection among Pregnant Women in Rural Mysore Taluk, India.Evaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries.Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessmentPopulation and dyadic-based seroincidence of herpes simplex virus-2 and syphilis in southern India.Rise in seroprevalence of herpes simplex virus type 1 among highly sexual active homosexual men and an increasing association between herpes simplex virus type 2 and HIV over time (1984-2003).Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam.Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon regionClinical assessment of assays for diagnosis of herpes simplex infection.Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.The epidemiology of herpes simplex virus type-2 infection among married women in Mysore, India.Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.Gender differences in the prevalence of sexually transmitted infections and genital symptoms in an urban setting in southern India.Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of PolandHSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.Hormonal contraceptive use and risk of HIV-1 disease progressionPerformance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes.Incident HSV-2 infections are common among HIV-1-discordant couples.Serologic detection of herpes simplex virus type 2 antibodies among pregnant women using a point-of-care test from Focus Diagnostics.Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study.Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan.Estimating seroprevalence of herpes simplex virus type 1 among different Middle East and North African male populations residing in Qatar.Seroprevalence of Herpes Simplex Virus type-2 (HSV-2) among pregnant women who participated in a national HIV surveillance activity in Haiti.False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands.
P2860
Q24812650-88A76D9A-F6DE-4D47-98D2-B74D5396CDD7Q26861777-734C0A76-E642-4949-B2E9-BCE2B8C8ECFDQ33436735-B098E6DA-FB94-4963-88BD-5547EFFC0B3FQ33646202-29FFA0A9-2796-4ECD-90BB-D740B8B8C35DQ33801040-AF8078AE-72E1-4ABD-9449-D3E6C0EFD172Q33835357-66E14DEC-5DE0-4C33-9EA4-B46DCFB0404FQ33849495-9A71A23E-AF15-49FF-A4FF-1A1A8CB53315Q33917477-164AC170-338C-4797-9F05-91986A2500E7Q33984223-41FD873B-9E86-4CAF-BF6B-57D19AB810E6Q34670442-CA885E21-4359-4D0E-9DC3-658BA92A0365Q34720324-F5B849D4-0C39-4719-B5AC-847386CA7480Q34734012-B9E047E4-0054-4725-B89D-B1A114FA606AQ34995329-BACEB836-7749-41CE-BB97-35579FBA12A0Q35138634-E8E78964-E647-4B71-9EC2-04B021FFBDD7Q35142513-370FDE57-62F6-4C75-84FF-566CAD3F1213Q35209414-4C3C2E78-A2FC-4B83-9BA7-EF919858A2F1Q35623695-FB59A458-C377-4D34-B00E-98C038CC4917Q35641538-609F8302-5917-4052-9B9E-8661850C7EC8Q35699938-9DD30219-A406-44AA-A54D-B7CA209CF708Q35794339-D9D3D959-6E74-428F-A60F-9D07C1F87463Q35899557-1017664E-2214-4C63-80DF-FCA274CDA2A4Q36360870-6D307FC4-8563-4E10-8E09-7BE28AB38F07Q36452397-8D21025C-A448-46CA-984B-1E5E558ADF86Q36529002-443A2BDF-1A7B-48B7-A4E4-6AADA31E80D3Q36607303-EBD5F69F-BF09-43B8-AB5B-D11D8832BD96Q36672554-7BAB2264-9EE3-41FA-8115-7231FB9737BCQ36731872-68CCA64A-779B-46B2-8937-AD74274F348FQ36747513-45952BE0-FDE9-424E-8809-BD4B62DEE263Q36928704-49437765-BEF8-4653-920C-BCD80DB79084Q36930412-E5BE6B27-ACC5-4530-AD15-50A9D398C222Q37043264-200EDA47-C7FF-4978-A7E1-83C747BDE60AQ37088950-D6EF1935-EDDF-4473-B630-986AAD1B4657Q37110895-1C8F1E9F-A7D9-450C-9815-09F20525DE20Q37145745-0AA91ACF-8358-45D2-BF4A-754DE5D54937Q37277980-556E6BD8-EB25-4048-B408-C533E0FAFD43Q37516826-ACC66F5E-B6B2-4F9F-BBB3-5584D0116E78Q37583223-F7B19DCE-05B0-4BBE-97D8-89B420CA1D29Q40079770-92A7C854-BFDF-40FD-BD7A-780C9142068AQ40087881-B9E8CE74-D1BA-431B-A9C9-E1FDC641D174Q40836819-98F03858-A989-433D-BDF9-EFF8D23A6127
P2860
Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Performance of focus ELISA tes ...... iverse geographical locations.
@en
Performance of focus ELISA tests for herpes simplex virus type 1
@nl
type
label
Performance of focus ELISA tes ...... iverse geographical locations.
@en
Performance of focus ELISA tests for herpes simplex virus type 1
@nl
prefLabel
Performance of focus ELISA tes ...... iverse geographical locations.
@en
Performance of focus ELISA tests for herpes simplex virus type 1
@nl
P2093
P1476
Performance of focus ELISA tes ...... iverse geographical locations.
@en
P2093
Ashley-Morrow R
Nollkamper J
Robinson NJ
P304
P356
10.1111/J.1469-0691.2004.00836.X
P577
2004-06-01T00:00:00Z